Gallant Pet Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
- Investments
-
1
Gallant Pet General Information
Description
Developer of a pet health technology platform designed to deliver regenerative stem cell therapies for improved veterinary care. The company's platform offers standardized stem cell banking, allogeneic treatments, and controlled field trials of off-the-shelf stem cell therapies grounded in scalable science, enabling veterinarians in primary care settings to provide improved treatment options and better health outcomes for companion animals.
Contact Information
Website
www.gallant.com(Operating Subsidiary)
Corporate Office
- 10865 Road to the Cure
- Suite 101
- San Diego, CA 92121
- United States
Corporate Office
- 10865 Road to the Cure
- Suite 101
- San Diego, CA 92121
- United States
Gallant Pet Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gallant Pet Patents
Gallant Pet Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022380747-A1 | Primed uterine-derived regenerative cell compositions and uses thereof | Pending | 04-Nov-2021 | ||
| CA-3235721-A1 | Primed uterine-derived regenerative cell compositions and uses thereof | Pending | 04-Nov-2021 | ||
| EP-4426816-A1 | Primed uterine-derived regenerative cell compositions and uses thereof | Pending | 04-Nov-2021 | ||
| EP-4426816-A4 | Primed uterine-derived regenerative cell compositions and uses thereof | Pending | 04-Nov-2021 | ||
| US-20250019662-A1 | Primed uterine-derived regenerative cell compositions and uses thereof | Pending | 04-Nov-2021 | C12N5/0682 |
Gallant Pet Signals
Gallant Pet Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gallant Pet Acquisitions (1)
Gallant Pet’s most recent deal was a Merger/Acquisition with Cook Regentec (veterinary division). The deal was made on 24-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cook Regentec (veterinary division) | 24-Oct-2019 | Merger/Acquisition | Other Healthcare Services |
Gallant Pet FAQs
-
When was Gallant Pet founded?
Gallant Pet was founded in 2018.
-
Where is Gallant Pet headquartered?
Gallant Pet is headquartered in San Diego, CA.
-
What is the size of Gallant Pet?
Gallant Pet has 50 total employees.
-
What industry is Gallant Pet in?
Gallant Pet’s primary industry is Other Commercial Services.
-
Is Gallant Pet a private or public company?
Gallant Pet is a Private company.
-
What is Gallant Pet’s current revenue?
The current revenue for Gallant Pet is .
-
How much funding has Gallant Pet raised over time?
Gallant Pet has raised $60.4M.
-
Who are Gallant Pet’s investors?
2Future Holdings, 77 Ventures, Alpha Edison, Alumni Ventures, and BOLD Capital Partners are 5 of 25 investors who have invested in Gallant Pet.
-
When was Gallant Pet acquired?
Gallant Pet was acquired on 17-Nov-2026.
-
Who acquired Gallant Pet?
Gallant Pet was acquired by Dechra Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process